Curis has been granted a patent for a compound that can be used in the treatment of phosphoinositide 3-kinase related diseases, including cancer, as well as histone deacetylase related disorders. The patent also covers the use of the compound for diseases related to both histone deacetylase and phosphoinositide 3-kinase. GlobalData’s report on Curis gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
According to GlobalData’s company profile on Curis, cancer treatment biomarkers was a key innovation area identified from patents. Curis's grant share as of June 2023 was 1%. Grant share is based on the ratio of number of grants to total number of patents.
Treatment of phosphoinositide 3-kinase related diseases and disorders
A recently granted patent (Publication Number: US11654136B2) discloses a salt of a compound represented by a specific formula. The patent also claims a pharmaceutical composition comprising this salt and a pharmaceutically acceptable carrier. The composition is specifically adapted for oral administration and can be in the form of a tablet or a capsule.
The patent further specifies different variations of the salt, including the sodium salt, potassium salt, sulfate salt, and choline salt. This suggests that the compound can be combined with different salts to create various pharmaceutical compositions.
In particular, the patent highlights the sodium salt as a preferred option for the pharmaceutical composition in the form of a tablet or a capsule. However, it also mentions the possibility of using the potassium salt, choline salt, or sulfate salt in the same composition.
Overall, this patent provides protection for the specific salt of the compound and its use in a pharmaceutical composition. The patent's claims cover various options for the salt and the composition's form, allowing for flexibility in the development and commercialization of oral medications based on this compound.
To know more about GlobalData’s detailed insights on Curis, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies
